UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,313.40 +2.40 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,047.43 +991.04 (+2.15%)
FibroGen, Inc. (0IL8.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:00PM BST
| Previous close | 1.1704 |
| Open | 1.1900 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.1301 - 1.2296 |
| 52-week range | 0.3389 - 20.7950 |
| Volume | |
| Avg. volume | 28,076 |
| Market cap | 854,999 |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
- Zacks
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
- Zacks
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.
© 2024 Yahoo. All rights reserved.